Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Colwell

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Otolaryngologic Clinics of North America|April 8, 2023
Management of Subglottic CancerHayley Mann, Kristen Seligman, Nicholas Colwell, et al.
International Journal of Molecular Sciences|January 30, 2019
PARP-1/2 Inhibitor Olaparib Prevents or Partially Reverts EMT Induced by TGF-β in NMuMG CellsMichelle Schacke, Janani Kumar, Nicholas Colwell, et al.
Laryngoscope Investigative Otolaryngology|April 3, 2025
National Trends in Treatment of Acute Unilateral Vocal Fold Paralysis at Tertiary Care Voice CentersSydney Ring, Nicholas Colwell, Andrew J Bowen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Otolaryngologic Clinics of North America|April 8, 2023
Management of Subglottic CancerHayley Mann, Kristen Seligman, Nicholas Colwell, et al.
International Journal of Molecular Sciences|January 30, 2019
PARP-1/2 Inhibitor Olaparib Prevents or Partially Reverts EMT Induced by TGF-β in NMuMG CellsMichelle Schacke, Janani Kumar, Nicholas Colwell, et al.
Laryngoscope Investigative Otolaryngology|April 3, 2025
National Trends in Treatment of Acute Unilateral Vocal Fold Paralysis at Tertiary Care Voice CentersSydney Ring, Nicholas Colwell, Andrew J Bowen, et al.
Pageof 1